Stock NXTMH NEXSTIM PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nexstim Plc

Equities

NXTMH

FI4000506811

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki
Other stock markets
 11:02:01 2024-04-26 am EDT 		5-day change 1st Jan Change
2.26 EUR +1.35% Intraday chart for Nexstim Plc -0.44% -23.13%
Apr. 26 Nexstim plc Receives Order for A New NBS System 5 from an Existing Customer Hospital in Germany CI
Apr. 22 Nexstim Wins Order for Navigated Brain Stimulation System in US MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7.22 43 31.96 27.6 19.89 15.29 - -
Enterprise Value (EV) 1 9.231 44.58 30.66 26.65 19.89 16.89 16.19 15.29
P/E ratio -0.46 x -4.89 x -34.1 x 22.8 x -14.7 x -28.3 x 22.6 x 11.3 x
Yield - - - - - - - 2.21%
Capitalization / Revenue 2.16 x 10.5 x 5 x 2.9 x 2.74 x 1.78 x 1.37 x 1.13 x
EV / Revenue 2.76 x 10.8 x 4.79 x 2.8 x 2.74 x 1.96 x 1.45 x 1.13 x
EV / EBITDA -1.54 x -15 x -30.4 x 19.9 x - 56.3 x 10.8 x 6.65 x
EV / FCF - -16.4 x -8.25 x -60.8 x - 12.1 x 23.1 x 9.56 x
FCF Yield - -6.11% -12.1% -1.64% - 8.29% 4.32% 10.5%
Price to Book - - - 6.78 x - 7.29 x 5.51 x -
Nbr of stocks (in thousands) 628 4,396 6,687 6,715 6,766 6,766 - -
Reference price 2 11.50 9.780 4.780 4.110 2.940 2.260 2.260 2.260
Announcement Date 2/28/20 2/26/21 2/28/22 2/27/23 2/27/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3.348 4.114 6.398 9.527 7.246 8.6 11.2 13.5
EBITDA 1 -5.993 -2.966 -1.009 1.338 - 0.3 1.5 2.3
EBIT 1 -6.517 -3.333 -1.452 0.8403 -1.228 -0.5 0.8 1.7
Operating Margin -194.66% -81.01% -22.7% 8.82% -16.95% -5.81% 7.14% 12.59%
Earnings before Tax (EBT) 1 -6.777 -4.117 -0.7333 1.311 - -0.6 0.7 1.4
Net income 1 -6.783 -4.122 -0.8321 1.307 - -0.6 0.7 1.4
Net margin -202.58% -100.18% -13.01% 13.72% - -6.98% 6.25% 10.37%
EPS 2 -25.00 -2.000 -0.1400 0.1800 -0.2000 -0.0800 0.1000 0.2000
Free Cash Flow 1 - -2.725 -3.718 -0.4381 - 1.4 0.7 1.6
FCF margin - -66.23% -58.11% -4.6% - 16.28% 6.25% 11.85%
FCF Conversion (EBITDA) - - - - - 466.67% 46.67% 69.57%
FCF Conversion (Net income) - - - - - - 100% 114.29%
Dividend per Share 2 - - - - - - - 0.0500
Announcement Date 2/28/20 2/26/21 2/28/22 2/27/23 2/27/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 6.793 2.734 2.504 4.743 3.7 4.9 4.5 6.6
EBITDA 1 2.553 -1.215 -1.078 - -0.3 0.6 -0.4 1.2
EBIT 1 2.333 -1.493 -1.387 0.1593 -0.7 0.2 -0.4 1.2
Operating Margin 34.35% -54.62% -55.41% 3.36% -18.92% 4.08% -8.89% 18.18%
Earnings before Tax (EBT) 1 3.214 -1.902 -1.439 - -0.8 0.2 -0.4 1.2
Net income 1 3.209 -1.903 -1.442 - -0.8 0.2 -0.4 1.2
Net margin 47.25% -69.6% -57.61% - -21.62% 4.08% -8.89% 18.18%
EPS 2 0.4400 -0.2800 -0.2100 - -0.1100 0.0200 -0.0500 0.1700
Dividend per Share - - - - - - - -
Announcement Date 8/12/22 2/27/23 8/18/23 2/27/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2.01 1.59 - - - 1.6 0.9 -
Net Cash position 1 - - 1.3 0.95 - - - -
Leverage (Debt/EBITDA) -0.3355 x -0.5356 x - - - 5.333 x 0.6 x -
Free Cash Flow 1 - -2.72 -3.72 -0.44 - 1.4 0.7 1.6
ROE (net income / shareholders' equity) - - - 35.9% - -23.6% 28.2% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - - 0.6100 - 0.3100 0.4100 -
Cash Flow per Share 2 - - - 0.1400 - 0.2700 0.1900 -
Capex 1 0.84 - 1.61 1.44 - 0.6 0.7 0.7
Capex / Sales 25.19% - 25.14% 15.12% - 6.98% 6.25% 5.19%
Announcement Date 2/28/20 2/26/21 2/28/22 2/27/23 2/27/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.26 EUR
Average target price
3 EUR
Spread / Average Target
+32.74%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
NEXSTIM PLC Stock Nexstim Plc
-23.13% 16.32M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. NXTMH Stock
  4. Financials Nexstim Plc